{
  "retracted": false,
  "timestamp": 1541030400000,
  "updates": [
    {
      "timestamp": 1592007079556,
      "identifier": {
        "doi": "10.1158/1078-0432.ccr-18-2742"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/1078-0432.ccr-10-1927"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors"
}
